Nomura Holdings’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-83,800
Closed -$8.46M 1907
2023
Q4
$8.46M Buy
+83,800
New +$8.09M 0.02% 499
2023
Q2
Sell
-140,400
Closed -$12.9M 1550
2023
Q1
$12.9M Buy
+140,400
New +$12.3M 0.04% 294
2022
Q4
Sell
-64,800
Closed -$4.92M 1623
2022
Q3
$4.92M Buy
+64,800
New +$5.37M 0.02% 562
2019
Q3
Sell
-50,400
Closed -$4.63M 1338
2019
Q2
$4.63M Buy
+50,400
New +$4.27M 0.02% 496
2015
Q1
Sell
-1,618,200
Closed -$134M 2125
2014
Q4
$134M Hold
1,618,200
0.36% 41
2014
Q3
$137M Buy
1,618,200
+390,600
+32% +$31.6M 0.37% 50
2014
Q2
$99.2M Sell
1,227,600
-55,800
-4% -$4.39M 0.03% 89
2014
Q1
$97.2M Buy
+1,283,400
New +$93.5M 0.03% 76

Other funds holding NVS

Nomura Holdings's NVS Position: Q2 2026 in Review

Nomura Holdings reduced its Novartis (NVS) stake by 5.1% in Q2 2026, selling an estimated $750K and leaving 94,009 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #443.

Nomura Holdings first reported a position in NVS in Q3 2013 and has held it in 12 quarters since. The position peaked at $15.1M in Q1 2026. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Nomura Holdings held 94,009 shares of Novartis worth $14.7M as of Q2 2026.
  • Nomura Holdings sold 5,004 Novartis shares in Q2 2026, an estimated $750K.
  • Novartis made up 0.02% of Nomura Holdings's portfolio in Q2 2026, its #443 holding.
  • Nomura Holdings first reported a position in Novartis in Q3 2013 and has held it in 12 quarters since.
  • Nomura Holdings's Novartis position peaked at $15.1M in Q1 2026.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.